Identification of an autophagy-related gene expression signature for colorectal cancer

References

• Abu N, Othman N, Ab Razak NS, Bakarurraini N, Nasir SN, Soh JEC, Mazlan L, Azman ZAM, Jamal R. 2020. Extracellular vesicles derived from colorectal cancer affects CD8 T cells: An analysis based on body Mass index. Front Cell Dev Biol. 8:564648. doi:10.3389/fcell.2020.564648.
   Web of Science ®Google Scholar
• Ait-Aissa K, Nguyen QM, Gabani M, Kassan A, Kumar S, Choi SK, Gonzalez AA, Khataei T, Sahyoun AM, Chen C, Kassan M. 2020. MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy. Cardiovasc Diabetol. 19(1):136. doi:10.1186/s12933-020-01107-3.
   Web of Science ®Google Scholar
• Al Bandar MH, Kim NK. 2017. Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review). Oncol Rep. 37(5):2553–2564. doi:10.3892/or.2017.5531.
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. 2017. The Eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 67(2):93–99. doi:10.3322/caac.21388.
   PubMed Web of Science ®Google Scholar
• An Y, Bi F, You Y, Liu X, Yang Q. 2018. Development of a novel autophagy-related prognostic signature for serous ovarian cancer. J Cancer. 9(21):4058–4071. doi:10.7150/jca.25587.
   PubMed Web of Science ®Google Scholar
• Bagherniya M, Butler AE, Barreto GE, Sahebkar A. 2018. The effect of fasting or calorie restriction on autophagy induction: A review of the literature. Ageing Res Rev. 47:183–197. doi:10.1016/j.arr.2018.08.004.
   PubMed Web of Science ®Google Scholar
• Chowdhury S, Pradhan RN, Sarkar RR. 2013. Structural and logical analysis of a comprehensive hedgehog signaling pathway to identify alternative drug targets for glioma, colon and pancreatic cancer. PLoS One. 8(7):e69132. doi:10.1371/journal.pone.0069132.
   Web of Science ®Google Scholar
• Conroy MJ, Lysaght J. 2020. CX3CL1 signaling in the tumor microenvironment. Adv Exp Med Biol. 1231:1–12. doi:10.1007/978-3-030-36667-4_1.
   Web of Science ®Google Scholar
• Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, et al. 2013. Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell. 23(5):634–646. doi:10.1016/j.ccr.2013.03.022.
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. 2019. Colorectal cancer. Lancet. 394(10207):1467–1480. doi:10.1016/s0140-6736(19)32319-0.
   PubMed Web of Science ®Google Scholar
• Fang Y, Ji L, Zhu C, Xiao Y, Zhang J, Lu J, Yin J, Wei L. 2020. Liraglutide alleviates hepatic steatosis by activating the TFEB-regulated autophagy-lysosomal pathway. Front Cell Dev Biol. 8:602574. doi:10.3389/fcell.2020.602574.
   PubMed Web of Science ®Google Scholar
• Huang Z, Liu J, Luo L, Sheng P, Wang B, Zhang J, Peng SS. 2019. Genome-wide identification of a novel autophagy-related signature for colorectal cancer. Dose Response. 17(4):1559325819894179. doi:10.1177/1559325819894179.
   Web of Science ®Google Scholar
• Khoo KH, Verma CS, Lane DP. 2014. Drugging the p53 pathway: Understanding the route to clinical efficacy. Nat Rev Drug Discov. 13(3):217–236. doi:10.1038/nrd4236.
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. 2017. Targeting autophagy in cancer. Nat Rev Cancer. 17(9):528–542. doi:10.1038/nrc.2017.53.
   PubMed Web of Science ®Google Scholar
• Li J, Guo BC, Sun LR, Wang JW, Fu XH, Zhang SZ, Poston G, Ding KF. 2014. TNM staging of colorectal cancer should be reconsidered by T stage weighting. World J Gastroenterol. 20(17):5104–5112. doi:10.3748/wjg.v20.i17.5104.
   PubMed Web of Science ®Google Scholar
• Li M, Jin C, Xu M, Zhou L, Li D, Yin Y. 2017. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling. Cell Commun Signal. 15(1):52. doi:10.1186/s12964-017-0208-8.
   PubMed Web of Science ®Google Scholar
• Li T, Mu N, Yin Y, Yu L, Ma H. 2020. Targeting AMP-activated protein kinase in aging-related cardiovascular diseases. Aging Dis. 11(4):967–977. doi:10.14336/ad.2019.0901.
   PubMed Web of Science ®Google Scholar
• Li J, Yi CH, Hu YT, Li JS, Yuan Y, Zhang SZ, Zheng S, Ding KF. 2016. TNM staging of colorectal cancer should be reconsidered according to weighting of the T stage: Verification based on a 25-year follow-up. Medicine (Baltimore. 95(6):e2711. doi:10.1097/md.0000000000002711.
   Web of Science ®Google Scholar
• Li XL, Zhou J, Chen ZR, Chng WJ. 2015. P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation. World J Gastroenterol. 21(1):84–93. doi:10.3748/wjg.v21.i1.84.
   PubMed Web of Science ®Google Scholar
• Maloverjan A, Piirsoo M, Michelson P, Kogerman P, Osterlund T. 2010. Identification of a novel serine/threonine kinase ULK3 as a positive regulator of Hedgehog pathway. Exp Cell Res. 316(4):627–637. doi:10.1016/j.yexcr.2009.10.018.
   PubMed Web of Science ®Google Scholar
• Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S. 2019. Early-onset colorectal cancer in young individuals. Mol Oncol. 13(2):109–131. doi:10.1002/1878-0261.12417.
   PubMed Web of Science ®Google Scholar
• Mo S, Dai W, Xiang W, Li Y, Feng Y, Zhang L, Li Q, Cai G. 2019. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer. Carcinogenesis. 40(7):861–870. doi:10.1093/carcin/bgz031.
   PubMed Web of Science ®Google Scholar
• Mokarram P, Albokashy M, Zarghooni M, Moosavi MA, Sepehri Z, Chen QM, Hudecki A, Sargazi A, Alizadeh J, Moghadam AR, et al. 2017. New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets. Autophagy. 13(5):781–819. doi:10.1080/15548627.2017.1290751.
   PubMed Web of Science ®Google Scholar
• Packer M. 2020. Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs. Cardiovasc Diabetol. 19(1):62. doi:10.1186/s12933-020-01041-4.
   PubMed Web of Science ®Google Scholar
• Patel M, Horgan PG, McMillan DC, Edwards J. 2018. NF-κB pathways in the development and progression of colorectal cancer. Transl Res. 197:43–56. doi:10.1016/j.trsl.2018.02.002.
   PubMed Web of Science ®Google Scholar
• Shi F, Li T, Liu Z, Qu K, Shi C, Li Y, Qin Q, Cheng L, Jin X, Yu T, et al. 2018. FOXO1: Another avenue for treating digestive malignancy? Semin Cancer Biol. 50:124–131. doi:10.1016/j.semcancer.2017.09.009.
   Web of Science ®Google Scholar
• Steinmann S, Kunze P, Hampel C, Eckstein M, Bertram Bramsen J, Muenzner JK, Carlé B, Ndreshkjana B, Kemenes S, Gasparini P, et al. 2019. DAPK1 loss triggers tumor invasion in colorectal tumor cells. Cell Death Dis. 10(12):895. doi:10.1038/s41419-019-2122-z.
   Google Scholar
• Su Q, Wang Y, Zhao J, Ma C, Wu T, Jin T, Xu J. 2015. Polymorphisms of PRLHR and HSPA12A and risk of gastric and colorectal cancer in the Chinese Han population. BMC Gastroenterol. 15:107. doi:10.1186/s12876-015-0336-9.
   Web of Science ®Google Scholar
• Wang SS, Chen G, Li SH, Pang JS, Cai KT, Yan HB, Huang ZG, He RQ. 2019. Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients. Onco Targets Ther. 12:3695–3712. doi:10.2147/ott.S197676.
   PubMed Web of Science ®Google Scholar
• Wei R, Xiao Y, Song Y, Yuan H, Luo J, Xu W. 2019. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis. J Exp Clin Cancer Res. 38(1):112. doi:10.1186/s13046-019-1043-0.
   PubMed Web of Science ®Google Scholar
• Xie J, Yan Y, Liu F, Kang H, Xu F, Xiao W, Wang H, Wang Y. 2019. Knockdown of Rab7a suppresses the proliferation, migration, and xenograft tumor growth of breast cancer cells. Biosci Rep. 39:2. doi:10.1042/bsr20180480.
   Web of Science ®Google Scholar
• Xu JL, Yuan L, Tang YC, Xu ZY, Xu HD, Cheng XD, Qin JJ. 2020. The role of autophagy in gastric cancer chemoresistance: Friend or foe? Front Cell Dev Biol. 8:621428. doi:10.3389/fcell.2020.621428.
   PubMed Web of Science ®Google Scholar
• Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, et al. 2017. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 170(3):548–563. e516. doi:10.1016/j.cell.2017.07.008.
   PubMed Web of Science ®Google Scholar
• Zhao YG, Zhang H. 2019. Core autophagy genes and human diseases. Curr Opin Cell Biol. 61:117–125. doi:10.1016/j.ceb.2019.08.003.
   PubMed Web of Science ®Google Scholar
• Zhou X, Lin N, Zhang M, Wang X, An Y, Su Q, Du P, Li B, Chen H. 2020. Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer. BMC Endocr Disord. 20(1):170. doi:10.1186/s12902-020-00647-9.
   Web of Science ®Google Scholar